Clearmind Converts $687.5K of Notes at $1.00, Amends Floor Price
CMND sits 29% above its 52-week low of $1.43.
Summary
Clearmind converted $687.5K of convertible notes at $1.00 per share and amended the floor price to $1.00, issuing registered shares that can be sold immediately.
Key Events · Financing and Capital Events · CMND
-
Note Conversion at $1.00
Two CLA investors converted $687,500 principal ($696,079.50 including accrued interest) into common shares at $1.00 per share, below today's $1.85 price.
-
Floor Price Amended to $1.00
The floor price in the convertible note form attached to the SPAs was amended to $1.00 per common share, lowering the conversion floor for future conversions.
-
Registered Shares Issued
Conversion shares are registered for resale and issued without restrictive legends, allowing immediate sale by the note holders.
-
Existing Financing Program
This conversion is part of the previously announced $10 million convertible note program under the SPAs dated September 17, 2025, as amended April 30, 2026.
Analysis · CMND · Life Sciences
Clearmind Medicine converted $687,500 of convertible notes (plus accrued interest, totaling $696,079.50) into common shares at $1.00 per share, and simultaneously amended the floor price on its outstanding notes to $1.00. The conversion price is below today's $1.85 market price, meaning the note holders receive shares at a discount to current trading levels. The shares are registered and issued without restrictive legends, so they can be sold immediately, creating potential near-term selling pressure. The floor price amendment also lowers the conversion floor for future note conversions, which could increase dilution if the stock price declines.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 29.9% of the 1988 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CMND was trading at $1.85 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.7M. The 52-week trading range was $1.43 to $524.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.